ARHGAP9 report

Query

Invalid input gene. Please select from the suggestions.

I. Expression across cell types

Cell ontologyData table

Name	Number of supported studies	Average coverage
natural killer cell	35 studies	37% ± 12%	Explore
CD8-positive, alpha-beta T cell	26 studies	25% ± 8%	Explore
CD4-positive, alpha-beta T cell	20 studies	23% ± 5%	Explore
regulatory T cell	20 studies	29% ± 9%	Explore
T cell	19 studies	24% ± 6%	Explore
CD16-negative, CD56-bright natural killer cell, human	15 studies	43% ± 16%	Explore
mature NK T cell	15 studies	32% ± 11%	Explore
CD16-positive, CD56-dim natural killer cell, human	15 studies	45% ± 12%	Explore
gamma-delta T cell	15 studies	33% ± 14%	Explore
plasmacytoid dendritic cell	14 studies	32% ± 12%	Explore
B cell	13 studies	22% ± 6%	Explore
CD8-positive, alpha-beta memory T cell	12 studies	30% ± 10%	Explore
naive B cell	12 studies	22% ± 8%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	11 studies	25% ± 5%	Explore
classical monocyte	11 studies	27% ± 8%	Explore
memory B cell	10 studies	21% ± 8%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	10 studies	20% ± 2%	Explore
CD4-positive, alpha-beta memory T cell	8 studies	22% ± 6%	Explore
effector memory CD8-positive, alpha-beta T cell	8 studies	28% ± 6%	Explore
mucosal invariant T cell	8 studies	22% ± 5%	Explore
innate lymphoid cell	7 studies	32% ± 10%	Explore
non-classical monocyte	6 studies	24% ± 9%	Explore
exhausted T cell	5 studies	33% ± 7%	Explore
effector CD8-positive, alpha-beta T cell	5 studies	25% ± 4%	Explore
T follicular helper cell	5 studies	27% ± 2%	Explore
dendritic cell	5 studies	29% ± 13%	Explore
conventional dendritic cell	4 studies	30% ± 11%	Explore
myeloid cell	4 studies	23% ± 3%	Explore
macrophage	4 studies	18% ± 3%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	23% ± 3%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	4 studies	25% ± 5%	Explore
neutrophil	3 studies	26% ± 8%	Explore
leukocyte	3 studies	23% ± 3%	Explore
hematopoietic precursor cell	3 studies	22% ± 4%	Explore
lymphocyte	3 studies	26% ± 12%	Explore
effector CD4-positive, alpha-beta T cell	3 studies	24% ± 3%	Explore
monocyte	3 studies	19% ± 3%	Explore
group 3 innate lymphoid cell	3 studies	37% ± 3%	Explore
double negative thymocyte	3 studies	32% ± 6%	Explore

II. Expression across tissues

sc-RNAseq dataData table

Name	Number of supported studies	Average coverage
peripheral blood	13 studies	24% ± 4%	Explore

Bulk RNAseq dataData table

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
lung	100%	3908.19	578 / 578	92%	7.74	1060 / 1155
stomach	74%	600.52	265 / 359	79%	5.13	227 / 286
breast	73%	560.08	337 / 459	79%	5.37	884 / 1118
kidney	67%	686.80	60 / 89	81%	6.17	731 / 901
intestine	75%	1864.42	725 / 966	73%	4.66	383 / 527
bladder	76%	890.29	16 / 21	65%	4.86	330 / 504
thymus	70%	758.76	460 / 653	68%	8.78	409 / 605
uterus	54%	325.16	91 / 170	83%	6.36	380 / 459
prostate	77%	745.05	189 / 245	49%	2.15	248 / 502
brain	43%	302.53	1124 / 2642	84%	5.26	592 / 705
esophagus	50%	357.90	728 / 1445	68%	3.61	124 / 183
liver	73%	529.77	166 / 226	44%	2.61	180 / 406
pancreas	18%	118.66	58 / 328	85%	7.96	152 / 178
adrenal gland	75%	550.44	194 / 258	27%	0.99	61 / 230
lymph node	0%	0	0 / 0	100%	51.00	29 / 29
peripheral blood	100%	28094.98	929 / 929	0%	0	0 / 0
spleen	100%	17120.54	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	93%	11.25	42 / 45
adipose	93%	1200.39	1117 / 1204	0%	0	0 / 0
skin	13%	69.25	235 / 1809	73%	8.22	346 / 472
ovary	19%	111.06	34 / 180	63%	2.92	269 / 430
blood vessel	49%	491.01	652 / 1335	0%	0	0 / 0
heart	33%	215.17	284 / 861	0%	0	0 / 0
eye	0%	0	0 / 0	18%	1.17	14 / 80
muscle	2%	8.05	14 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1